These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9210288)
1. Anti-HIV active naphthyl analogues of HEPT and DABO. Danel K; Nielsen C; Pedersen EB Acta Chem Scand (Cph); 1997 Mar; 51(3 Suppl):426-30. PubMed ID: 9210288 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel N-1 (allyloxymethyl) analogues of 6-benzyl-1-(ethoxymethyl)-5-isopropyluracil (MKC-442, emivirine) with improved activity against HIV-1 and its mutants. El-Brollosy NR; Jørgensen PT; Dahan B; Boel AM; Pedersen EB; Nielsen C J Med Chem; 2002 Dec; 45(26):5721-6. PubMed ID: 12477355 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-HIV-1 activity of new MKC-442 analogues with an alkynyl-substituted 6-benzyl group. Aly YL; Pedersen EB; La Colla P; Loddo R Arch Pharm (Weinheim); 2007 May; 340(5):225-35. PubMed ID: 17464964 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and characterization of the antitumor activity of novel ceramide analogues. Macchia M; Barontini S; Bertini S; Di Bussolo V; Fogli S; Giovannetti E; Grossi E; Minutolo F; Danesi R J Med Chem; 2001 Nov; 44(23):3994-4000. PubMed ID: 11689086 [TBL] [Abstract][Full Text] [Related]
5. Nonnucleoside HIV-1 reverse transcriptase inhibitors: Part I. Synthesis and structure-activity relationship of 1-alkoxymethyl-5-alkyl-6-naphthylmethyl uracils as HEPT analogues. Meng G; Chen FE; De Clercq E; Balzarini J; Pannecouque C Chem Pharm Bull (Tokyo); 2003 Jul; 51(7):779-89. PubMed ID: 12843582 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel MKC-442 analogues with potent activities against HIV-1. El-Brollosy NR; Pedersen EB; Nielsen C Arch Pharm (Weinheim); 2003 Jul; 336(4-5):236-41. PubMed ID: 12916058 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of new potential HIV-1 non-nucleoside reverse transcriptase inhibitors. New analogues of MKC-442 containing Michael acceptors in the C-6 position. Petersen L; Jessen CH; Pedersen EB; Nielsen C Org Biomol Chem; 2003 Oct; 1(20):3541-5. PubMed ID: 14599015 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of 6-(3,5-dichlorobenzyl) derivatives as isosteric analogues of the HIV drug 6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil (GCA-186). Sørensen ER; El-Brollosy NR; Jørgensen PT; Pedersen EB; Nielsen C Arch Pharm (Weinheim); 2005 Jul; 338(7):299-304. PubMed ID: 15996003 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of novel 6-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents. Khalifa NM; Pedersen EB; Nielsen C; Al-Omar MA Bioorg Khim; 2014; 40(5):629-35. PubMed ID: 25895358 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel fluoro analogues of MKC442 as microbicides. Loksha YM; Pedersen EB; Loddo R; Sanna G; Collu G; Giliberti G; La Colla P J Med Chem; 2014 Jun; 57(12):5169-78. PubMed ID: 24805780 [TBL] [Abstract][Full Text] [Related]
12. Multiple pathways in the synthesis of new annelated analogues of 6-benzyl-1-(ethoxymethyl)-5-isopropyluracil (emivirine). Therkelsen FD; Hansen AL; Pedersen EB; Nielsen C Org Biomol Chem; 2003 Aug; 1(16):2908-18. PubMed ID: 12968341 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-hepatitis B activity of new substituted uracil and thiouracil glycosides. Abdel-Aal MT Arch Pharm Res; 2010 Jun; 33(6):797-805. PubMed ID: 20607483 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and anti-HIV-1 activity of 1-aromatic methyl-substituted 3-(3,5-dimethylbenzyl)uracil and N-3,5-dimethylbenzyl-substituted urea derivatives. Sakakibara N; Baba M; Okamoto M; Toyama M; Demizu Y; Misawa T; Kurihara M; Irie K; Kato Y; Maruyama T Antivir Chem Chemother; 2015 Feb; 24(1):3-18. PubMed ID: 26149262 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-HIV-1 activity of novel 2,3-dihydro-7H-thiazolo[3,2-a]pyrimidin-7-ones. Danel K; Pedersen EB; Nielsen C J Med Chem; 1998 Jan; 41(2):191-8. PubMed ID: 9457243 [TBL] [Abstract][Full Text] [Related]
16. Non-nucleoside HIV reverse transcriptase inhibitors, Part 6[1]: synthesis and anti-HIV activity of novel 2-[(arylcarbonylmethyl)thio]-6-arylthio DABO analogues. Sun GF; Kuang YY; Chen FE; De Clercq E; Balzarini J; Pannecouque C Arch Pharm (Weinheim); 2005 Oct; 338(10):457-61. PubMed ID: 16211654 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of (S)-1-(2',3'-dihydroxypropyl)-2-alkylthiouracils as new antiviral agents. Rahman AA; Aal MT Pharmazie; 1998 Jun; 53(6):377-80. PubMed ID: 9675767 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activity of 5-diethylaminomethyl derivatives and nitrogen mustards of uracil and 2-thiouracils. Fabrissin S; de Nardo M; Nisi C; Morasca L; Dolfini E; Franchi G J Med Chem; 1976 May; 19(5):639-42. PubMed ID: 1271405 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel uracil non-nucleoside derivatives as potential reverse transcriptase inhibitors of HIV-1. El-Brollosy NR; Al-Deeb OA; El-Emam AA; Pedersen EB; La Colla P; Collu G; Sanna G; Loddo R Arch Pharm (Weinheim); 2009 Nov; 342(11):663-70. PubMed ID: 19856332 [TBL] [Abstract][Full Text] [Related]
20. The design and synthesis of N-1-alkylated-5-aminoarylalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors. Lu X; Chen Y; Guo Y; Liu Z; Shi Y; Xu Y; Wang X; Zhang Z; Liu J Bioorg Med Chem; 2007 Dec; 15(23):7399-407. PubMed ID: 17870545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]